Trial Profile
A Phase I, Randomized, Open-label, 2-arm Parallel-design Study to Determine the Effect of Multiple-dose Rifampin on the Pharmacokinetics, Safety and Tolerability of Single-dose Enzalutamide in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary) ; Rifampicin
- Indications Breast cancer; Prostate cancer
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 20 May 2014 New trial record